PATHOGENESIS OF CORONAVIRUS INFECTION COVID-19
DOI:
https://doi.org/10.11603/1681-2727.2020.3.11555Keywords:
pathogenesis, pathomorphology, coronavirus infection, SARS-CoV-2, COVID-19Abstract
Coronavirus SARS-CoV-2, penetrates through the mucous membranes of the respiratory tract and enterocytes of the small intestine through ACE2 receptors. Most ACE2 is expressed on the surface of cells of the respiratory tract, especially on type I and II alveolocytes, which explains the lung damage in infected people. Disruption of the gas exchange process associated with damage to the alveoli and capillaries leads to hypoxemia and secondary (indirect) damage to internal organs and systems. The pathogen SARS-CoV-2, which uses the ACE2 receptor to penetrate cells, is promoted by proteases that are inside these cells. ACE2 activity is due, in particular, IFN, the role and participation of which in the infectious process is being studied. The development of systemic vasculitis due to the tropism of the glycoprotein of coronavirus to endothelial cells that have the ACE receptor also indirectly leads to pathological changes in the lungs, heart, brain, kidneys, gastrointestinal tract. As a result of endothelial dysfunction and programmed necrotic cell death (apoptosis and piroptosis) in COVID-19, there is a systemic violation of microcirculation in the vascular bed of various organs and systems, which characterizes the clinical manifestations and consequences in infected. The autoimmune mechanism of defeat of internals is not excluded also. Binding of SARS-CoV-2 to receptors on the cell surface leads to an inflammatory process with the production of pro-inflammatory cytokines, the concentration of which can be extremely high in the form of the so-called “cytokine storm” that underlies ARDS and MODS. The risk of death is directly associated with high serum IL-6 levels.
After 5-7 days from the onset of the disease there is interstitial pneumonia, initially focal, which quickly turns into drainage. The system of mononuclear phagocytes is affected; lymphopenia develops, IFN synthesis is suppressed. Coronavirus pneumonia can be complicated by the accession of bacterial flora, as evidenced by increased levels of procalcitonin in the serum, it also occurs when the patient’s condition worsens. In addition, the patient’s severity is accompanied by high levels of CRP, LDH, D-dimer, ferritin and the like. At the same time there are changes in the blood coagulation system. The level of hemoglobin decreases, which aggravates the hypoxic syndrome.
Pathomorphological changes of ARDS include acute exudative and productive phases. In the first phase, signs of diffuse alveolar damage, acute bronchiolitis, edema and hemorrhage of interstitial tissue predominate. The productive phase is characterized by the development of fibrosing alveolitis with the organization of exudate in the lumen of the alveoli and bronchioles. coronavirus infection can also cause serious damage to other internal organs and systems.
Thus, pathomorphological changes in infected SARS-CoV-2 are due to the direct action of nCoV, hyperactivity of the immune system, high levels of cytotoxicity of CD8 + T cells, autoimmune processes and the like.
References
Tyrrell, D.A.J., & Bynoe, M.L. (1966). Cultivation of viruses from a high proportion of patients with colds. Lancet, 76-7. DOI: 10.1016/S0140-6736(66)92364-6. DOI: https://doi.org/10.1016/S0140-6736(66)92364-6
Velavan, T. P., & Meyer, C. G. (2020). The COVID-19 epidemic. Tropical Medicine & International Health, 25 (3), 278. DOI: 10.1111/tmi.13383. DOI: https://doi.org/10.1016/S0140-6736(20)30937-5.
Prompetchara, E., Ketloy, C., & Palaga, T. (2020). Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac. J. Allergy Immunol., 38 (1), 1-9. DOI: 10.12932/AP-200220-077.
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., ... & Müller, M. A. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. https://doi.org/10.1016/j.cell.2020.02.052. DOI: https://doi.org/10.1016/j.cell.2020.02.052
Qi, F., Qian, S., Zhang, S., & Zhang, Z. (2020). Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochemical and Biophysical Research Communications. DOI: 10.1016/j.bbrc.2020.03.044. DOI 10.12932/AP-200220-0772. DOI: https://doi.org/10.1016/j.bbrc.2020.03.044
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., ... & Tian, D. S. (2020). Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clinical Infectious Diseases. DOI: 10.1093/cid/ciaa248. DOI: https://doi.org/10.1093/cid/ciaa248
Zhang H. (2020). Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Medicine, 46 (4). 586-590. DOI:10.1007/s00134-020-05985-9.
Zou, X., Chen, K., Zou, J., Han, P., Hao, J., & Han, Z. (2020). Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Frontiers of Medicine, 1-8. DOI: 10.1007/s11684-020-0754-0. DOI: https://doi.org/10.1007/s11684-020-0754-0
Lai, C. C., Liu, Y. H., Wang, C. Y., Wang, Y. H., Hsueh, S. C., Yen, M. Y., ... & Hsueh, P. R. (2020). Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2): facts and myths. Journal of Microbiology, Immunology and Infection. pii:S1684-1182(20)30040-2. DOI: 10.1016/j.jmii.2020.02.012. DOI: https://doi.org/10.1016/j.jmii.2020.02.012
Li, Z., Huang, Y., & Guo, X. (2020). The brain, another potential target organ, needs early protection from SARS-CoV-2 neuroinvasion. Sci. China Life Sci., 63 (5), 771-773. https://doi.org/10.1007/s11427-020-1690-y. DOI: https://doi.org/10.1007/s11427-020-1690-y
Varga, Z., Flammer, A.J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A.S., ... & Moch, H. (2020). Endothelial cell infection and endotheliitis in COVID-19. The Lancet, 395 (10234), 1417-1418. DOI: https://doi.org/10.1016/S0140-6736(20)30937-5. DOI: https://doi.org/10.1016/S0140-6736(20)30937-5
Kuster, G.M., Pfister, O., Burkard, T., Zhou, Q., Twerenbold, R., Haaf, P., ... & Osswald, S. (2020). SARS-CoV-2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? European Heart Journal, 41 (19), 1801-1803. https://doi.org/10.1093/eurheartj/ehaa235. DOI: https://doi.org/10.1093/eurheartj/ehaa235
Zhang, W., Zhao, Y., Zhang, F., Wang, Q., Li, T., Liu, Z., ... & Zeng, X. (2020). The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The experience of clinical immunologists from China. Clinical Immunology, 108393. DOI: 10.1016/j.clim.2020.108393. DOI: https://doi.org/10.1016/j.clim.2020.108393
Davies, J., Randeva, H.S., Chatha, K., Hall, M., Spandidos, D.A., Karteris, E., & Kyrou, I. (2020). Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19. Molecular Medicine Reports, 22 (5), 4221-4226. https://doi.org/10.3892/mmr.2020.11510 DOI: https://doi.org/10.3892/mmr.2020.11510
Song, J., & Ruan, Q. (2000). Mechanism of ligustrazini against thrombosis. Chinese Medical Journal, 113 (2), 136. https://doi.org/10.1002/1097-0320(20000801)40:4<271::AID-CYTO3>3.0.CO;2-C. DOI: https://doi.org/10.1002/1097-0320(20000801)40:4<271::AID-CYTO3>3.0.CO;2-C
Ziegler, C.G., Allon, S.J., Nyquist, S.K., Mbano, I.M., Miao, V.N., Tzouanas, C.N., ... & Feldman, J. (2020). SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell, 181 (5),1016-1035. e19. https://doi.org/10.1016/j.cell.2020.04.035. DOI: https://doi.org/10.1016/j.cell.2020.04.035
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., ... & Cheng, Z. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395 (10223), 497-506. DOI:10.1016/S0140-6736(20)30183-5. DOI: https://doi.org/10.1016/S0140-6736(20)30183-5
Lippi, G., & Mattiuzzi, C. (2020). Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. Hematology, Transfusion and Cell Therapy. pii:S2531-1379(20)30029-8. DOI: 10.1016/j.htct.2020.03.001. DOI: https://doi.org/10.1016/j.htct.2020.03.001
Bell, T.J., Zhang, M., Cubillos, P.E., Dang, L., Fossati, L., Todorov, K.O., ... & Crossfield, I.J. (2019). Mass loss from the exoplanet WASP-12b inferred from Spitzer phase curves. Monthly Notices of the Royal Astronomical Society, 489 (2), 1995-2013. https://doi.org/10.1093/mnras/stz2018. DOI: https://doi.org/10.1093/mnras/stz2018
Heldin, P., Lin, C.Y., Kolliopoulos, C., Chen, Y.H., & Skandalis, S.S. (2019). Regulation of hyaluronan biosynthesis and clinical impact of excessive hyaluronan production. Matrix Biology, 78, 100-117. https://doi.org/10.1016/j.matbio.2018.01.017. DOI: https://doi.org/10.1016/j.matbio.2018.01.017
Hanff, T.C., Harhay, M.O., Brown, T.S., Cohen, J.B., & Mohareb, A.M. (2020). Is there an association between COVID-19 mortality and the renin-angiotensin system – a call for epidemiologic investigations. Clinical Infectious Diseases, 71 (15), 870-874. https://doi.org/10.1093/cid/ciaa329. DOI: https://doi.org/10.1093/cid/ciaa329
Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A.S. (2020). Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Medicine, 46 (4), 586-590. DOI:10.1007/s00134-020-05985-9. DOI: https://doi.org/10.1007/s00134-020-05985-9
Downloads
Published
How to Cite
Issue
Section
License
Journal Infectious Disease (Infektsiini Khvoroby) allows the author(s) to hold the copyright without registration
Users can use, reuse and build upon the material published in the journal but only for non-commercial purposes
This journal is available through Creative Commons (CC) License BY-NC "Attribution-NonCommercial" 4.0